About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 389672, 7 pages
http://dx.doi.org/10.1155/2013/389672
Research Article

Positron Emission Tomography as a Surrogate Marker for Evaluation of Treatment Response in Patients with Desmoid Tumors under Therapy with Imatinib

1Sarcoma Unit, ITM—Interdisciplinary Tumor Center Mannheim, Mannheim University Medical Center, University of Heidelberg, Theodor-Kutzer-Ufer 1–3, 68167 Mannheim, Germany
2Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
3Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1–3, 68167 Mannheim, Germany

Received 11 March 2013; Accepted 7 May 2013

Academic Editor: Aleksandra Nikolic

Copyright © 2013 Bernd Kasper et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bernd Kasper, Antonia Dimitrakopoulou-Strauss, Lothar R. Pilz, Ludwig G. Strauss, Christos Sachpekidis, and Peter Hohenberger, “Positron Emission Tomography as a Surrogate Marker for Evaluation of Treatment Response in Patients with Desmoid Tumors under Therapy with Imatinib,” BioMed Research International, vol. 2013, Article ID 389672, 7 pages, 2013. doi:10.1155/2013/389672